Skip to main content

Table 5 Inhibition of C. perfringens hemolytic activity after incubation with MYR, ZnO, ZnO/PVA, and ZnO/PVA/MYR

From: Antimicrobial potential of myricetin-coated zinc oxide nanocomposite against drug-resistant Clostridium perfringens

No.

Sample code

MYR

  

ZnO

  

ZnO/PVA

  

ZnO/PVA/MYR

  

MIC

MIC/2

MIC/4

MIC

MIC/2

MIC/4

MIC

MIC/2

MIC/4

MIC

MIC/2

MIC/4

1

19M 

21.6

48.7

67.4

52.4

72.3

87

48.7

60.7

77.3

11.5

20.02

44.2

2

27L

19.8

35

58

49

69

78

40.3

58.9

69.7

10.8

19.3

40.3

3

125

16.9

29

49

40.2

59

69

31.8

49.3

58.9

9.9

18.7

39.4

  1. The hemolysis activity was calculated as hemolysis percentage
  2. ZnO zinc oxoid, PVA polyvinyl alcohol, MYR myricetin, MIC minimum inhibitory concentration, MBC minimum bactericidal concentration